PixarBio (PixarBio) Additional Paid-In Capital : $0.59 Mil(As of Sep. 2016)

View and export this data going back to 2016. Start your Free Trial

What is PixarBio Additional Paid-In Capital?

PixarBio's quarterly additional paid-in capital stayed the same from Mar. 2016 ($0.35 Mil) to Jun. 2016 ($0.35 Mil) but then increased from Jun. 2016 ($0.35 Mil) to Sep. 2016 ($0.59 Mil).

PixarBio's annual additional paid-in capital increased from . 20 ($0.00 Mil) to Dec. 2014 ($0.35 Mil) but then stayed the same from Dec. 2014 ($0.35 Mil) to Dec. 2015 ($0.35 Mil).

PixarBio Additional Paid-In Capital Historical Data

The historical data trend for PixarBio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Additional Paid-In Capital Chart

PixarBio Annual Data

Trend

Dec14

Dec15

Additional Paid-In Capital

0.35

PixarBio Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Additional Paid-In Capital	Get a 7-Day Free Trial					0.35	0.35	0.35	0.35	0.59

PixarBio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

PixarBio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PixarBio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

PixarBio (PixarBio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155

Website

https://www.pixarbio.com

PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.